This article is more than 5 years old. Information may no longer be current.
Yogurt may lower lung cancer risk, FDA recommends boxed warning on breast implants — top stories in hematology/oncology
Click Here to Manage Email Alerts
Findings that people who ate large amounts of yogurt and dietary fiber had a decreased risk for lung cancer was the top story in hematology/oncology last week.
Another top story was the FDA recommendation for boxed warnings on breast implant labeling to ensure patients are completely informed about the benefits and potential risks of implants.
Eating more yogurt, dietary fiber may reduce lung cancer risk
Adults who consumed large amounts of dietary fiber and yogurt demonstrated decreased risk for lung cancer, regardless of several risk factors, according to results of a pooled analysis published in JAMA Oncology. Read more.
FDA calls for boxed warning on breast implants
The FDA issued draft guidance today recommending inclusion of a boxed warning on breast implant labeling to ensure women receive and understand complete information about their benefits and potential risks. Read more.
Urine test predicts prostate cancer progression, need for treatment
A urine test developed by researchers at University of East Anglia and Norfolk and Norwich University Hospital in the U.K. appeared to accurately predict whether men with prostate cancer will need treatment as many as 5 years earlier than current methods. Read more.
Vincristine shortage underscores vulnerability of ‘fragile market’ for crucial treatments
A shortage of the chemotherapy drug vincristine, which is essential to the treatment of most pediatric cancers, has left the oncology community struggling to find short-term solutions while recognizing the need for long-term reform. Read more.
Anxiety, depression linked to pain intensity among patients with cancer
Higher levels of anxiety and depression among patients with cancer appeared to be associated with more severe disease-related pain, according to study results scheduled for presentation at Supportive Care in Oncology Symposium. Read more.